Population
In vitro platelet assays and an in vivo rabbit model of thrombus formation
Comparison
cGMP-elevating agents, MAP kinase inhibitor, and… vs Control (implied)
Design
Preclinical
Authors
Loading...
Src inhibition and sildenafil reduce thrombosis in rabbits; hypothesis-generating for human antithrombotic strategies pending clinical data.
Src kinases, but not MAP kinases, are critical for VWF-dependent platelet activation, while cGMP-elevating agents like sildenafil inhibit this process.
Marshall et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: